🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I, open-label, 2-part study in patients with a confirmed di...
Status
Completed
Location
Research Site
Start Date
2014-12-22
Trial ID
NCT02197234
This is a Phase I, open-label, 2-part study in patients with a confirmed di...
Status
Completed
Location
Research Site
Start Date
2014-12-04
Trial ID
NCT02197247
To assess the pharmacokinetics of TY-9591 tablets and Osimertinib Mesylate ...
Status
Completed
Location
Hunan Provincial Tumor Hospital
Start Date
2021-04-30
Trial ID
NCT04798638
Treatments Being Tested
Protocol Title A Study to Evaluate ANS014004 in Combination with EGFR-TKI ...
Status
Not Yet Recruiting
Location
Memorial Sloan Kettering Cancer Center David H, Koch Center lor Cancer Care
Start Date
2026-06
Trial ID
NCT07285148
Treatments Being Tested
The trial consists of a series of parallel multi-centre single arm phase II...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2015-05-13
Trial ID
NCT02664935
This is a Phase 1/2, open-label, multicenter, sequential dose-escalation st...
Status
Completed
Location
Site 2
Start Date
2018-04-20
Trial ID
NCT03446417
Treatments Being Tested
This is a 2-part study in patients with epidermal growth factor receptor mu...
Status
Completed
Location
Research Site
Start Date
2014-11-14
Trial ID
NCT02163733
This is a 2 part study in patients with EGFRm+ non small cell lung cancer (...
Status
Completed
Location
Research Site
Start Date
2014-11-06
Trial ID
NCT02157883
Treatments Being Tested
This is a 2-part study in patients with advanced solid tumours. Part A will...
Status
Completed
Location
Research Site
Start Date
2014-12-22
Trial ID
NCT02161770
The purpose of this study is to assess the effect of severe renal impairmen...
Status
Completed
Location
Research Site
Start Date
2017-05-04
Trial ID
NCT02923947
Treatments Being Tested